Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Telavive
Ari Raphael
29 anos de experiência
acreditações :
Clínica certificada :
| Israel | Turquia | Áustria | |
| Terapia de protão | de $48,000 | de $70,000 | de $80,000 |
| Sistema Robótico Da Vinci | de $22,500 | de $9,500 | de $22,000 |
| Radiocirurgia estereotáxica | de $19,000 | de $4,500 | de $17,000 |
| Quimioterapia para câncer do pulmão | de $3,200 | de $1,000 | de $19,200 |
| Lobectomia | de $23,171 | de $7,300 | de $30,000 |
A Clínica Assuta é o maior centro médico privado de Israel. O hospital especializa-se em oncologia, ortopedia, neurocirurgia, cirurgia cardíaca e tratamento de infertilidade. 13% de todas as operações no país são realizadas na Assuta, o que a torna um centro cirúrgico líder.
Pela qualidade e segurança no tratamento, o hospital recebeu a acreditação americana da Joint Commission International.
Anualmente, os médicos da rede Assuta realizam mais de 92.000 operações, 685.000 procedimentos diagnósticos e 16.000 ciclos de FIV.
O Professor Ofer Merimsky é especialista em cancro do pulmão e desenvolveu protocolos de tratamento inovadores para fases precoces e avançadas da doença.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
O Dr. Ari Raphael lidera ensaios clínicos inovadores em cancro do pulmão no Sourasky Medical Center, focando-se em perfis genómicos e imunoterapia.
Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.
He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.
Israeli oncologists use advanced genetic screening and biomarker analysis to determine treatment candidacy. Next-generation sequencing (NGS) identifies driver mutations like EGFR and ALK for targeted therapy. Immunotherapy eligibility depends primarily on PD-L1 expression levels and microsatellite instability (MSI) testing within JCI-accredited facilities.
Bookimed Expert Insight: Israeli oncology centres like Sheba and Sourasky serve over 400,000 patients annually, creating a massive data pool for precision medicine. Leading specialists like Dr Ofer Merimsky utilize this volume to refine treatment protocols. Their experience with over 900 procedures helps them identify which patients will benefit most from targeted drugs versus standard chemotherapy.
Patient Consensus: Patients in Israel note that comprehensive mutation testing often shifts treatment plans away from chemo. They find that confirming tissue quality early prevents the need for repeat biopsies during the diagnostic phase.
Israel offers advanced lung cancer care including immunotherapy, targeted therapy, and robotic surgery. Centres use molecular profiling to identify genetic mutations. This allows for precision medicines like osimertinib. High-tech radiation like CyberKnife and VMAT provides non-invasive options for complex or inoperable tumours.
Bookimed Expert Insight: Israeli oncology centres like Sheba and Sourasky serve over 1,800,000 patients annually. They often provide access to novel therapies through clinical trials before they are widely available. For instance, Dr Ofer Merimsky at Sourasky has overseen over 900 procedures. This volume ensures specialists handle even the most complex Stage IV cases with high proficiency.
Patient Consensus: Patients in Israel value the fast, integrated diagnostic work-up. They note that molecular profiling often unlocks new targeted therapy options that were not available in their home countries.
Patients can obtain a remote second opinion from Israeli specialists before travelling. Major centres use telehealth frameworks for international case reviews. Senior oncologists evaluate diagnostic files and scans via video platforms. This process confirms diagnoses and outlines advanced treatment roadmaps digitally.
Bookimed Expert Insight: Israeli oncology centres excel at molecular matching for lung cancer. Specialists like Dr Nir Peled and Dr Jair Bar focus on specific genetic mutations. An early remote review can confirm if advanced immunotherapies like Keytruda are suitable. This often prevents unnecessary travel for patients whose cases don't require surgical intervention.
Patient Consensus: Individuals note that remote reviews provide clarity on local treatment plans versus Israeli options. Many find that sending full pathology and genetic testing results ensures the most accurate remote assessment. Patients from Australia value comparing these expert Israeli insights with their local multi-disciplinary team recommendations.
Israel's leading lung cancer oncologists include Prof. Ofer Merimsky at Sourasky Medical Center, Prof. Jair Bar at Sheba Medical Center, and Prof. Nir Peled at Herzliya Medical Center. These specialists lead major thoracic units. They focus on personalised immunotherapy and advanced targeted treatments.
Bookimed Expert Insight: Israeli oncology centres like Sheba and Sourasky serve over 400,000 patients annually. They often combine treatments into single-visit protocols. This efficiency is why medical tourists rank Israel among the top 10 global destinations. These JCI-accredited facilities offer rare specialised services like celiac plexus radiosurgery and CAR-T immunotherapy.
Patient Consensus: Patients in Israel emphasise finding specialists who join multidisciplinary tumour boards. They note it is essential to complete biomarker testing like EGFR or PD-L1 before finishing any long-term treatment plan.
Patients should plan for a total stay of 3 to 14 days in Israel for diagnostics or surgery. Complex therapies like radiotherapy or chemotherapy cycles can extend this period to 8 weeks. Specialists use JCI-accredited facilities in Tel Aviv and Haifa to manage rapid diagnostic workups.
Bookimed Expert Insight: Israeli oncology centres like Sheba and Sourasky often compress multi-step diagnostics into 72 hours. While a diagnostic package may only require 5 hotel nights, patients should note that pathology record transfers can cause delays. Bringing original pathology slides from Australia or requesting digital genomic profiling interpretation in advance can shave 4 days off the initial stay.
Patient Consensus: Patients note that staging and specialist reviews take longer than expected, making flexible return flights essential. Experience at Sourasky showed that everything was organised in a timely manner, but individuals should always confirm when they are medically cleared for the long-haul flight back to Australia.
Lung cancer care in Israel involves a multidisciplinary team led by medical oncologists, thoracic surgeons, and radiotherapists. Experts like Professor Ofer Merimsky and Professor Nir Peled specialize in personalized immunotherapy and innovative chemo-radiotherapy protocols within JCI-accredited centers to improve patient results.
Bookimed Expert Insight: Leading Israeli specialists often hold dual certifications or rare combinations of expertise. For example, Dr. Raphael Pfeffer is board-certified in both oncology and radiology. This allows a single expert to oversee both the tumor biology and the high-tech imaging required for precise radiation planning.
Patient Consensus: Patients often mention how comfortable they feel when doctors explain the whole process in simple terms. One patient noted that the coordination between the surgeon and the oncologist made them feel their care was a joint effort.
Lung cancer doctors in Israel specialize in personalized treatments using molecular genetic profiling and immunotherapy. Experts like Dr. Nir Peled at Herzliya Medical Center and Dr. Ari Raphael at Sourasky Medical Center tailor therapies based on genomic sequencing to target specific tumor mutations.
Bookimed Expert Insight: Israeli specialists often hold dual qualifications in oncology and biology. Prof. Jair Bar and Prof. Raanan Berger both hold PhDs in molecular biology. This allows them to translate laboratory genomic data directly into personalized clinical protocols for advanced lung cancer cases.
Patient Consensus: Patients often feel relieved when specialists review their tumor genetics to suggest targeted drugs. They notice a clear focus on finding specific treatments that work for their unique cancer stage.
Israeli lung cancer doctors lead global research in immunotherapy and genomic medicine. Specialists like Dr. Nir Peled and Dr. Ari Raphael chair international committees and lead innovative molecular trials. These doctors integrate real-time research with clinical care to provide personalized therapies for advanced thoracic malignancies.
Bookimed Expert Insight: Israeli oncology centers like Sheba and Sourasky operate dedicated translational research units within the hospital. This means researchers like Dr. Raanan Berger and Dr. Yaacov Lawrence can immediately apply lab findings to patient care. Patients benefit from this integration because the most senior specialists often serve as principal investigators for international phase I-III clinical trials.
Patient Consensus: Patients emphasize the importance of asking about genetic testing and immunotherapy trials before beginning standard care. They felt more confident when doctors clearly explained how newer research protocols could work alongside traditional surgery or radiation.
Thoracic surgeons in Israel perform advanced surgeries using minimally invasive VATS and Da Vinci robotic systems. Specialists like Dr. Lael Anson Best at Rambam Medical Center have completed 1,000+ complex procedures. They focus on lung-sparing techniques like segmentectomy to preserve healthy tissue and speed up recovery.
Bookimed Expert Insight: Israeli thoracic surgeons often integrate molecular genetics into surgical planning. Dr. Jair Bar at Sheba Medical Center heads a unit focusing on immunotherapy and genetics. This ensures that surgery is part of a personalized plan, especially for patients with advanced or treatment-resistant cancer.
Patient Consensus: Many patients prioritize asking about lung-sparing options like segmentectomy over traditional lobectomy to maintain better breathing capacity. They noticed that while recovery is faster with robotic surgery, managing post-operative fatigue and drains remains a vital step.
Specialists in Israel determine lung cancer treatment plans through multidisciplinary tumor boards where surgeons, oncologists, and radiologists collaborate. They use genomic profiling and T-cell sequencing to identify specific mutations, ensuring every patient receives a personalized therapy roadmap based on their unique biology.
Bookimed Expert Insight: Israeli lung cancer specialists often hold dual certifications in oncology and radiotherapy. For example, Dr. Raphael Pfeffer at Assuta and Dr. Jair Bar at Sheba are board-certified in both. This dual expertise allows one doctor to manage both radiation and drug therapy. This integration usually leads to faster transitions between treatment phases compared to separate departments.
Patient Consensus: Patients often mention how quickly doctors move from the first consultation to a full treatment plan. Many were surprised that a single specialist could coordinate both their chemotherapy and radiation sessions efficiently.